Principal
Current—Advises publicly and privately held corporate clients on their strategic alliances, ranging from traditional mergers and acquisitions, joint ventures, and securities offerings to complex, cutting-edge intellectual property licensing. —Author of more than 50 articles on corporate, securities, regulatory, and IP law issues; frequent speaker at pharmaceutical and biotechnology industry events.—Co-Editor-in-Chief of American Bar Association’s treatise, “Biotechnology and the Law” (1st Ed.).—Past Chair of the American Bar Association’s Section of Science & Technology Law, its Life Sciences Division, and its Biotechnology Committee.